Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF - TIMI 48 Trial. [electronic resource]
Producer: 20191121Description: e008987 p. digitalISSN:- 2047-9980
- Aged
- Anticoagulants -- therapeutic use
- Atrial Fibrillation -- complications
- Comorbidity
- Embolism -- etiology
- Factor Xa Inhibitors -- therapeutic use
- Female
- Gastrointestinal Neoplasms -- epidemiology
- Hemorrhage -- chemically induced
- Humans
- Lung Neoplasms -- epidemiology
- Male
- Middle Aged
- Neoplasms -- epidemiology
- Proportional Hazards Models
- Prostatic Neoplasms -- epidemiology
- Pyridines -- therapeutic use
- Stroke -- etiology
- Thiazoles -- therapeutic use
- Warfarin -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.